Herbal Medications and Anesthesia Case Management.

Area of Science:

• Pharmacology
• Integrative Medicine
• Patient Safety

Background:

• Herbal medicine use is rising in the U.S.
• Patients frequently do not disclose herbal product consumption to healthcare providers.
• The U.S. Food and Drug Administration (FDA) lacks stringent oversight for herbal supplements.

Purpose of the Study:

• To inform anesthesia providers about the risks associated with herbal medicine use in the perioperative setting.
• To highlight the importance of understanding potential drug interactions and contaminants in herbal supplements.
• To address the anesthetic implications for patients using these products.

Main Methods:

• Literature review on herbal medicine use, FDA regulations, and perioperative considerations.
• Analysis of potential interactions between common herbal supplements and anesthetic agents.
• Evaluation of the impact of contaminants and product variability on patient safety.

Main Results:

• Lack of FDA regulation results in significant variability in herbal supplement quality, purity, and efficacy.
• Herbal medicines can have adverse interactions with conventional medications, particularly during the perioperative period.
• Contamination of herbal products is a substantial risk, posing unknown dangers to patients.

Conclusions:

• Anesthesia providers must be knowledgeable about common herbal supplements, their purported uses, and potential risks.
• Disclosure of herbal medicine use by patients is critical for safe perioperative management.
• Increased vigilance and awareness are necessary to mitigate risks associated with herbal products in anesthesia care.